Medtronic (NYSE:MDT) this week touted results from a three-month clinical trial of the recently acquired Stimgenics Differential Target Multiplexed Spinal Cord Stimulation using Medtronic’s Intellis platform. The large, multicenter randomized controlled trial showed that 80% of patients with chronic back pain that were treated with Differential Target Multiplexed (DTM) reported at least 50% pain relief […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
Phoenix Children’s Hospital to deploy Medtronic neurosurgery robot
Phoenix Children’s Hospital will be the first health system in the U.S. to deploy the newly FDA-cleared Medtronic Stealth Autoguide platform to perform robotic neurosurgery on pediatric patients. The Barrow Neurological Institute (BNI) at Phoenix Children’s will use Stealth Autoguide with Medtronic’s StealthStation system. The hospital expects procedures to start later this month, according to […]
Polyganics’ Liqoseal sealant patch wins CE mark approval
Polyganics announced that it is initiating the European launch of its Liqoseal dural sealant patch after it won CE Mark approval. The Groningen, The Netherlands–based company’s Liqoseal dural sealant patch is designed to reduce cerebrospinal fluid (CSF) leakage following elective cranial surgery. Liqoseal’s European approval follows the Encase I clinical trial, which revealed an absence […]
Triplet Therapeutics launches with $59 million in funding
Biotechnology company Triplet Therapeutics announced that it launched earlier this week with $59 million in financing as it develops ways to treat certain types of genetic disorders at their source. The $59 million includes a $49 million Series A financing round led by MPM Capital and Pfizer Ventures U.S. Co-founder Atlas Venture seeded Triplet with $10 million […]
Medtronic wins FDA clearance for brain surgery guidance system
Medtronic (NYSE:MDT) today said it won FDA clearance for its cranial robotic platform the Stealth Autoguide system. The Stealth Autoguide Platform is a robotic guidance system that is designed for spatial positioning and orientation of instrument holders and tool guides that are used in neurosurgical procedures. “Medtronic continues to deliver on its commitment of developing innovative […]
Natus Medical issues field safety notice for snap electrode leads
Natus Medical (NSDQ:NTUS) issued an urgent field safety notice to warn users of an incompatible electrode lead connector in gold cup electrodes and snap electrode leads. The affected components are used for audiological, neurological or vestibular testing. The devices include cables that may be red, orange, yellow, green, blue, brown, black or white, according to the […]
NOUS Imaging picks up $6.6m for brain-imaging software
NOUS Imaging announced that it picked up $6.6 million in venture capital and government research investments for its software-based biofeedback solution. The St. Louis, Mo.–based company is developing the Framewise integrated real-time MRI monitoring (FIRMM) system for acquiring better brain MR exams. FIRMM initially only worked with Siemens MR scanners, but NOUS Imaging said it […]
Stimwave Technologies stops commercialization of products in Australia
Stimwave Technologies announced today that it is stopping the commercialization of its product lines in Australia until its entire product family can be legally marketed in the country. The neuromodulation therapy alternative developer’s products include the Freedom SCS system and the StimQ PNS system, which are designed to reduce the risks associated with implantable pulse […]
Penumbra appoints new chief financial and accounting officers
Penumbra (NYSE:PEN) recently announced that it appointed Maggie Yuen as chief financial officer and Lambert Shiu as chief accounting officer, effective Dec. 2. Yuen replaces president and chief financial officer Sri Kosaraju. Kosaraju will continue to serve as president following the appointment. Prior to joining Penumbra, Yuen held a number of leadership roles in the manufacturing, […]
InVivo prices $1m public stock offering
InVivo Therapeutics (NSDQ:NVIV) announced that it priced a public stock offering expected to produce gross proceeds of just under $1 million for the company. The Cambridge, Mass.-based company is offering 7 million shares of its common stock to the public at a price of 12¢ per share. InVivo expects the gross proceeds to reach $840,000, before […]
Philips launches its first clinical product for aiding cognitive assessment in the U.S.
Royal Philips (NYSE:PHG) announced the debut of its IntelliSpace Cognition cognitive assessment platform that uses artificial intelligence to aid healthcare professionals in assessing cognitive impairment. The Amsterdam-based company’s IntelliSpace Cognition system is designed to automate and enhance neuropsychological tests, providing access to detailed information about a patient’s cognition while offering quantitative longitudinal data to aid in […]